SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Myriad Genetics, Inc. (MYGN)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
2355 65 0 MYGN
Emcee:  s myers Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1280Time to death endpoint. Good one!! My guess is that 2 registration trials are kenhott-5/4/2005
1279Walter Gilbert is chair of the Compensation Committee. Nothing will shake him, scaram(o)uche-5/4/2005
1278A death endpoint for a AD trial makes no sense to me. The problem with AD is noZirdu-5/4/2005
1277The Board has been lazy and generous.scaram(o)uche-5/4/2005
1276Life expectancy of AD patient must be longer than prostrate cancers. FDA approveLee39-5/4/2005
1275<i>that is what is known as talking out of both sides of your mouth... <nigel bates-5/4/2005
1274CSFB out with another doozy saying that MYGN missed its target revenue number foRobohogs-5/4/2005
1273I was agreeing with you and Rick. Although JNJ and LLY almost killed SEPR. JonRobohogs-5/4/2005
1272ELN would have died twice from the 1st Crohn's trial close miss, and currentLee39-5/4/2005
1271the boys' club....... <i>On February 17, 2005 the Company entered intscaram(o)uche-5/4/2005
1270from 10-Q, nothing new...... On May 2, 2005, we announced the preliminascaram(o)uche-5/4/2005
1269That is stupid, stupid. JonRobohogs-5/4/2005
1268Unfortunately, Meldumb said in "PM, oncology and AD" MYGN will go it Lee39-5/4/2005
1267Of course, and makes no diff. ;-) The trial failed to reach endpoints, period,scaram(o)uche-5/4/2005
1266Agreed. And thanks for the laugh! JonRobohogs-5/4/2005
1265The 3 arms in the trial were placebo, 400 mg and 800 mg. There was no titrated dLee39-5/4/2005
1264I agree on that point but the Moderate/Mild and different dosage groups I would Robohogs-5/4/2005
1263JMP said it was not - but info would have come from Meldrum. I would think it mRobohogs-5/4/2005
1262Whichever analyst said that is nuts. Yeah, the "high plasma concentration&scaram(o)uche-5/4/2005
1261Do you trust the CSFB analyst or Meldrum ? One wrote it is and the other said iLee39-5/4/2005
1260Jon: Much of the value is in "first mover", IMO........ Message 2109scaram(o)uche-5/4/2005
1259One of the analyses I read of the subgroup analysis, said specifically that the Robohogs-5/4/2005
1258What do you think value is based on the numbers I posted (assume a bit higher foRobohogs-5/4/2005
1257The PM pipe is type II diabetes, obesity, depression and yet another cancer.scaram(o)uche-5/4/2005
1256Excellent. Sorry to interrupt, I am going back to my mouse hole.kenhott-5/4/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News